Clinical Trial: A Study of mRNA-1283.222 Injection Compared With mRNA-1273.222 Injection in Participants ?12 Years of Age to Prevent COVID-19
Study Status: ACTIVE_NOT_RECRUITING
Recruit Status: ACTIVE_NOT_RECRUITING
Condition: COVID-19
Study Type: INTERVENTIONAL
Official Title: A Randomized, Observer-Blind, Active-Controlled Phase 3 Study to Investigate the Safety, Immunogenicity, and Relative Vaccine Efficacy of mRNA-1283.222 Administered as a Booster Dose Compared With mRN
Brief Summary:
The purpose of this study is to evaluate the safety, reactogenicity, and relative vaccine efficacy (rVE) of the mRNA-1283.222vaccine as well as its immunogenicity in comparison to the mRNA-1273.222vaccine.
Read more